Lung Cancer, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Authors :
Sarah B. Goldberg & Roy S. Herbst
Date of Publication: 05/2023
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and mol ...view more
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more.
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more.
Key Features
Contains 15 relevant, practice-oriented topics including lung cancer screening; advances in surgical techniques for lung cancer; non-surgical therapy for early-stage lung cancer; locally advanced lung cancer; what’s new in small cell lung cancer; and more.
Provides in-depth clinical reviews on lung cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Sarah B. Goldberg, MD, MPH, Associate Professor of Medicine (Medical Oncology), Research Director, Center for Thoracic Cancers Associate Director, Hematology/Oncology Fellowship Program, Yale Comprehensive Cancer Center and Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.eu.elsevierhealth.com/lung-cancer-an-issue-of-hematologyoncology-clinics-of-north-america-9780443183065.html291460Lung Cancer, An Issue of Hematology/Oncology Clinics of North Americahttps://www.eu.elsevierhealth.com/media/catalog/product/9/7/9780443183065_2.jpg71.9995.99EURInStock/Medicine and Surgery/Haematology/Books/Clinics Review Articles9899525503956128371745498285145120In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more. In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more. 00add-to-cart97804431830652023ProfessionalEdited by Sarah B. Goldberg, MD, MPH and Roy S. Herbst, MD, PhD20231Book152w x 229h (6.00" x 9.00")Elsevier24012 May 2023PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSEdited by <STRONG>Sarah B. Goldberg</STRONG>, MD, MPH, Associate Professor of Medicine (Medical Oncology), Research Director, Center for Thoracic Cancers Associate Director, Hematology/Oncology Fellowship Program, Yale Comprehensive Cancer Center and <STRONG>Roy S. Herbst</STRONG>, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of MedicineClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
